Hydroxyurea remains effective long-term in reducing emergency department visits and hospital days for children living with ...

Hydroxyurea remains effective long-term in reducing emergency department visits and hospital days for children living with sickle cell disease (SCD), according to new research published in Blood ...

FIRST Postdoctoral Fellow Jasmine Hope (15C, 22G) emphasized the impact ending the FIRST program will have on the ...

Immigration and Customs Enforcement (ICE) recently forcibly restrained and arrested a Tufts University (Mass.) doctoral ...

BALTIMORE, April 15, 2025 (GLOBE NEWSWIRE) -- The Urology Care Foundation, the world’s leading nonprofit urological health foundation and the official foundation of the American Urological Association ...

After an earlier trial showed patients with elevated levels of a cardiac stress marker benefited from its cell therapy, the firm shifted focus to this subset.

Health policy is crucial for advancing clinical research and ensuring accessibility and funding for novel therapies.

The trial is assessing the therapy for individuals with ischemic heart failure of minimised ejection fraction.

CardiAMP HF II is Evaluating the CardiAMP™ Cell Therapy Product for Treating Patients with Ischemic Heart Failure of Reduced Ejection Fraction ...

Kevin Howell, chief external affairs officer for the University of North Carolina School of Medicine and UNC Health, has been ...

Emory University's PEACE for Moms program helps professionals connect their pregnant and postpartum patients with mental ...

The Center for Behavioral Neuroscience at Georgia State University is transforming our understanding of the brain through ...